848 results on '"Madonna, Rosalinda"'
Search Results
2. Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension
3. Inferior vena cava filters: Concept review and summary of current guidelines
4. Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review
5. Chronic thromboembolic pulmonary disease: Association with exercise-induced pulmonary hypertension and right ventricle adaptation over time
6. Endothelial heterogeneity and their relevance in cardiac development and coronary artery disease
7. Antineoplastic drugs inducing cardiac and vascular toxicity – An update
8. Exploring the significance of epicardial adipose tissue in aortic valve stenosis and left ventricular remodeling: Unveiling novel therapeutic and prognostic markers of disease
9. Editors’ Preamble to The Journal of Cardiovascular Aging
10. Biobanks: The unmet need in heart failure management
11. Transcriptional regulation of vascular smooth muscle cell proliferation, differentiation and senescence: Novel targets for therapy
12. Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside
13. Exercise-induced pulmonary hypertension in HFpEF and HFrEF: Different pathophysiologic mechanism behind similar functional impairment
14. Angiocrine endothelium: From physiology to atherosclerosis and cardiac repair
15. Sodium-glucose cotransporter type 2 inhibitors prevent ponatinib-induced endothelial senescence and disfunction: A potential rescue strategy
16. Vasostatins: new molecular targets for atherosclerosis, post-ischaemic angiogenesis, and arteriogenesis
17. Exercise-induced pulmonary hypertension in HIV patients: Association with poor clinical and immunological status
18. Exploring the mechanisms of action of gliflozines in heart failure and possible implications in pulmonary hypertension
19. Is it the time of seno-therapeutics application in cardiovascular pathological conditions related to ageing?
20. Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions
21. Global position paper on cardiovascular regenerative medicine
22. Transplantation of telomerase/myocardin-co-expressing mesenchymal cells in the mouse promotes myocardial revascularization and tissue repair
23. Prevention and Clinical Management of Cardiovascular Damage Induced by Anticancer Drugs: Need for Early Biomarkers and Cardio- and Vasculoprotection in Personalized Therapy
24. Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism
25. Association of the European Society of Cardiology echocardiographic probability grading for pulmonary hypertension with short and mid-term clinical outcomes after heart valve surgery
26. Atrial Strain Assessment for the Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio-Oncology)
27. Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens
28. Proteomic analysis of the secretome of adipose tissue-derived murine mesenchymal cells overexpressing telomerase and myocardin
29. Stem Cell Therapies for Cardiac Regeneration: Current Burden—Future Directions
30. Tissue Specific Progenitors/Stem Cells for Cardiac Regeneration
31. Induced Pluripotent Stem Cells for Cardiac Regeneration
32. Biology and Function of Stem Cells
33. Cell based mechanosensing in vascular patho-biology: More than a simple go-with the flow
34. Farmaci antineoplastici e tossicità cardiovascolare
35. The Nutrigenetics of Cardiovascular Disease
36. Contributors
37. Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death
38. Chronic thromboembolic disease: Association with exercise-induced pulmonary hypertension and right ventricle deterioration
39. Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities
40. Innate and adaptive immunity in atherosclerosis
41. Perivascular fibrosis and the microvasculature of the heart. Still hidden secrets of pathophysiology?
42. Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage
43. Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study
44. Autophagy, innate immunity, and cardiac disease
45. Animal models and animal-free innovations for cardiovascular research
46. Toll-like receptor-4 signaling pathway in aorta aging and diseases: “its double nature”
47. Long COVID and the cardiovascular system - elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases
48. Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases
49. Early Diagnosis and Prediction of Anticancer Drug-induced Cardiotoxicity: From Cardiac Imaging to “Omics” Technologies
50. Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.